ACA vs BSX · P/E 57, rev $2.88B vs P/E 20, rev $16.75B
Arcosa Inc (ACA) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the ACA and BSX stock pages for the full models.
Not investment advice.